In order to support the bioanalysis of various classes of compounds Bertin Pharma offers a large range of techniques and methods providing rapid high volume bioanalysis.

By Chemical Entities, we mean Chemical Substances or Drugs…

For these product candidates, Bertin Pharma offers capacities in

Drug Discovery & Translational Research for antimicrobial agents, anticancer agents, immunomodulators, etc.
> Non-clinical studies such as ADME & Toxicology including ImmunoToxicology
> Clinical studies as Central Lab but also as clinical supplier & for QC
> Drug analysis & Biomarkers including development of specific biomarker assays
> Pharmaceutical Development
> Biobanking
> Biosafety including Safety Pharmacology

Our method development processes focus on high-throughput technological capabilities (e.g. TurboFlow ).
Bertin Pharma offers an impressive number of validated bioanalysis methods, ready for use with a very short lead-time.

New Chemical Entities, Pharmaceutical Development, ADMET, Drug Formulation

Our method development processes focus on high-throughput technological capabilities (e.g. TurboFlow).
Bertin Pharma offers an impressive number of validated bioanalysis methods, ready for use with a very short lead-time.

We develop a number of different dosage forms such as:

• liquids; oral and topical, suspensions & emulsions
• semi-solids such as gels, controlled release gels, ointments, creams and suppositories
• powders and granules
• capsules, coated capsules, capsules filled with un-coated or coated particles
• tablets : immediate-release, coated , sustained release multiple layers
• parenterals and other sterile products

Our facilities and animal facilities, either BSL2/BSL3, GLP or GMP, can address all phases of drug development, even for infectious diseases.